Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DirkJan Hijnen

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
The Journal of Investigative Dermatology|June 12, 2009
Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skinSusan J Huang, Dirkjan Hijnen, George F Murphy, et al.
Acta Dermato-Venereologica|November 17, 2025
Successful Dose Reduction of Janus-kinase Inhibitors in Well-controlled Atopic Dermatitis: A Prospective, Multicentre, Real-world StudyAnne R Schlösser, Anouk G M Caron, Merle S Den Ouden, et al.
Clinical and Translational Allergy|August 16, 2024
Higher prevalence of dupilumab-induced ocular adverse events in atopic dermatitis compared to asthma: A daily practice analysisAnne R Schlösser, Lotte Bult, John C Thelen, et al.
Chemistry & Biology|November 10, 2015
Combinatorial Screening Identifies Novel Promiscuous Matrix Metalloproteinase Activities that Lead to Inhibition of the Therapeutic Target IL-13Carole Urbach, Nathaniel C Gordon, Ian Strickland, et al.
The Journal of Experimental Medicine|September 17, 2008
Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cellsRachael A Clark, Susan J Huang, George F Murphy, et al.
Cellular Immunology|September 17, 2020
Signal Inhibitory Receptor on Leukocytes-1 is highly expressed on lung monocytes, but absent on mononuclear phagocytes in skin and colonHelen J von Richthofen, Doron Gollnast, Toni M M van Capel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 4, 2015
Brief report: enrichment of activated group 3 innate lymphoid cells in psoriatic arthritis synovial fluidEmmerik F A Leijten, Tessa S van Kempen, Marianne Boes, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 24, 2021
Association between nasal and nasopharyngeal bacterial colonization in early life and eczema phenotypesChen Hu, Liesbeth Duijts, Evelien R van Meel, et al.
The Journal of Allergy and Clinical Immunology|April 17, 2017
Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysisJudith L Thijs, Ian Strickland, Carla A F M Bruijnzeel-Koomen, et al.
American Journal of Clinical Dermatology|March 26, 2024
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)Jonathan I Silverberg, Melinda J Gooderham, Amy S Paller, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Investigative Dermatology|June 12, 2009
Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skinSusan J Huang, Dirkjan Hijnen, George F Murphy, et al.
Acta Dermato-Venereologica|November 17, 2025
Successful Dose Reduction of Janus-kinase Inhibitors in Well-controlled Atopic Dermatitis: A Prospective, Multicentre, Real-world StudyAnne R Schlösser, Anouk G M Caron, Merle S Den Ouden, et al.
Clinical and Translational Allergy|August 16, 2024
Higher prevalence of dupilumab-induced ocular adverse events in atopic dermatitis compared to asthma: A daily practice analysisAnne R Schlösser, Lotte Bult, John C Thelen, et al.
Chemistry & Biology|November 10, 2015
Combinatorial Screening Identifies Novel Promiscuous Matrix Metalloproteinase Activities that Lead to Inhibition of the Therapeutic Target IL-13Carole Urbach, Nathaniel C Gordon, Ian Strickland, et al.
The Journal of Experimental Medicine|September 17, 2008
Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cellsRachael A Clark, Susan J Huang, George F Murphy, et al.
Cellular Immunology|September 17, 2020
Signal Inhibitory Receptor on Leukocytes-1 is highly expressed on lung monocytes, but absent on mononuclear phagocytes in skin and colonHelen J von Richthofen, Doron Gollnast, Toni M M van Capel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 4, 2015
Brief report: enrichment of activated group 3 innate lymphoid cells in psoriatic arthritis synovial fluidEmmerik F A Leijten, Tessa S van Kempen, Marianne Boes, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 24, 2021
Association between nasal and nasopharyngeal bacterial colonization in early life and eczema phenotypesChen Hu, Liesbeth Duijts, Evelien R van Meel, et al.
The Journal of Allergy and Clinical Immunology|April 17, 2017
Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysisJudith L Thijs, Ian Strickland, Carla A F M Bruijnzeel-Koomen, et al.
American Journal of Clinical Dermatology|March 26, 2024
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)Jonathan I Silverberg, Melinda J Gooderham, Amy S Paller, et al.
Pageof 4